To overcome market access challenges, life sciences companies must develop innovative strategies, structured market access teams, and an understanding of the influencers and stakeholders for a specific therapeutic area in each market.
KOL management is a vital tactic for ensuring product adoption and patient access. The growing importance of properly managing KOLs requires the structured and centralized processes, teams and systems.
Using virtual advisory boards, life sciences companies are reducing overheard costs while increasing the quality and effectiveness of their advisory boards.
It's crucial for any KOL management program to be compliant with legal restrictions regarding data privacy
Using a presentation management system, marketing and sales teams are saving significant overhead costs while increasing their field-team’s effectiveness.
Results from London workshop on EU, US, APAC and emerging markets’ regulations and KOL management. Findings relating to the collecting, storing and working with KOL data, transparency regulations including UK anti-bribery legislation and the Sunshine Act.
A leading pharmaceutical enterprise was conducting several clinical trials in various stages on a compound, and realized…
© 2011 Heartbeat Experts. All rights reserved